drugset / Trial / NCT01438372
IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD
Phase 2
Withdrawn
Wayne State University
American Regent, Inc. · collabChildren's Hospital of Michigan · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and efficacy of intravenous iron sucrose in comparison to oral ferrous sulfate in improving iron deficiency anemia in children with inflammatory bowel disease.
Timeline
- Start
- 2011-11
- Primary completion
- 2012-02
- Completion
- 2012-03
Outcome
Outcome not reported
Stopped (Enrollment): “The study was terminated prior to enrolling patients as we were unable to secure enough funding to complete the study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ferrous Sulfate | Diagnostic / imaging agent | 3 mg/kg | Oral |
| Subject | Iron sucrose | Unknown | — | Intravenous |